The Library
Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine
Tools
Tools
Tools
Daulton, Emma, Wicaksono, Alfian, Tiele, Akira, Kocher, Hemant M., Debernardi, Silvana, Crnogorac-Jurcevic, Tatjana and Covington, James A. (2021) Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine. Talanta, 221 . 121604. doi:10.1016/j.talanta.2020.121604
|
PDF
WRAP-volatile-organic-compounds-(VOCs)-non-invasive-detection-pancreatic-cancer-urine-Covington-2020.pdf - Accepted Version - Requires a PDF viewer. Download (766Kb) | Preview |
Official URL: http://dx.doi.org/10.1016/j.talanta.2020.121604
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a particularly challenging cancer, with very low 5-year survival rates. This low survival rate is linked to late stage diagnosis, associated with the lack of approved biomarkers. One approach that is receiving considerable attention is the use of volatile organic compounds (VOCs) that emanate from biological waste as biomarkers for disease. In this study, we used urine as our biological matrix and two VOC analysis platforms: gas chromatography – ion mobility spectrometry (GC-IMS) and GC time-of-flight mass spectrometry (GC-TOF-MS). We measured the urinary headspace of samples from patients with PDAC, chronic pancreatitis (CP) and healthy controls. In total, 123 samples were tested from these groups. Results indicate that both GC-IMS and GC-TOF-MS were able to discriminate PDAC from healthy controls with high confidence and an AUC (area under the curve) in excess of 0.85. However, both methods struggled to separate CP from PDAC, with the best result of AUC 0.58. This indicates that both conditions produce similar biomarkers in the urinary headspace. Chemical identification suggests that 2,6-dimethyl-octane, nonanal, 4-ethyl-1,2-dimethyl-benzene and 2-pentanone play an important role in separating these groups. Therefore, both techniques validate this approach in identifying subjects for further investigation in a clinical setting.
| Item Type: | Journal Article | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | |||||||||
| Divisions: | Faculty of Science > Engineering | |||||||||
| Library of Congress Subject Headings (LCSH): | Pancreas -- Cancer -- Diagnosis, Volatile organic compounds -- Health aspects, Pancreas -- Cancer -- Research -- Methodology, Pancreatitis, Diagnosis, Noninvasive, Urine -- Analysis | |||||||||
| Journal or Publication Title: | Talanta | |||||||||
| Publisher: | Elsevier | |||||||||
| ISSN: | 00399140 | |||||||||
| Official Date: | 1 January 2021 | |||||||||
| Dates: |
|
|||||||||
| Volume: | 221 | |||||||||
| Article Number: | 121604 | |||||||||
| DOI: | 10.1016/j.talanta.2020.121604 | |||||||||
| Status: | Peer Reviewed | |||||||||
| Publication Status: | Published | |||||||||
| Access rights to Published version: | Open Access | |||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
